Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women

British Journal of Nutrition

Volumn 89, Issue 4, 2003, Pages 467-474

  Blakesmith, Sarah J ^a   Lyons Wall, Philippa M ^a   George, Caroline ^a   Joannou, George E ^a   Petocz, Peter ^b   Samann, Samir ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Technology   (Australia)

Author keywords

Isoflavones; Lipids; Premenopausal women

Indexed keywords

BIOCHEMICAL MARKER; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOFLAVONE DERIVATIVE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CLOVER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; PARALLEL DESIGN; PREMENOPAUSE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TABLET; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; ISOFLAVONES; LIPIDS; LIPOPROTEINS; PHYTOTHERAPY; PREMENOPAUSE; TREATMENT FAILURE; TRIFOLIUM; TRIGLYCERIDES;

TRIFOLIUM; TRIFOLIUM PRATENSE;

EID: 0037650174     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2002807     Document Type: Article

References (42)

1. Abbey M, Owen A, Suzakawa M, Roach P & Nestel PJ (1999) effects of menopause and hormone replacement therapy on plama lipids, lipoproteins and LDL-receptor activity. Maturitas 33, 259-269.
2. Anderson JW, Johnstone BM & Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. New England Journal of Medicine 333, 276-282.
3. Anthony MS, Clarkson TB, Bullock BC & Wagner JD (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arteriosclerosis, Thrombosis and Vascular Biology 17, 2524-2531.
4. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM & Burke GL. (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. Journal of Nutrition 126, 43-50.
5. Baum JA, Teng H, Erdman JW Jr, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF & Potter SM (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. American Journal of Clinical Nutrition 68, 545-551.
6. Brinton EA. (1996) Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arteriosclerosis, Thrombosis and Vascular Biology 16, 431-440.
7. Carroll KK (1991) Review of clinical studies on cholesterol-lowering response to soy protein. Journal of the American Dietetic Association 91, 820-827.
8. Cassidy A, Bingham S & Setchell KD (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition 60, 333-340.
9. Cassidy A, Bingham S & Setchell K (1995) Biological effects of isoflavones in young women: Importance of the chemical composition of soyabean products. British Journal of Nutrition 74, 587-601.
10. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M & Burke GL (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Archives of Internal Medicine 159, 2070-2076.
11. Dahlen GH (1994) Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108, 111-126.
12. Franke AA, Custer LJ, Cerna CM & Narala K (1995) Rapid HPLC analysis of dietry phytoestrogens from legumes and from human urine. Proceedings of the Society for Experimental Biology and Medicine 208, 18-26.
13. Friedewald WT, Levy RI & Friedrickson DS (1972) Estimation of the concentrations of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18, 499-502.
14. Greaves KA, Parks JS, Williams JK & Wagner JD (1999) Intact dietary soy protein, but not adding in isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. Journal of Nutrition 129, 1585-1592.
15. Haines C, Chung T, Chang A, Masarei J, Tomlinson B & Wong E (1996) Effects of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. Archives of Internal Medicine 156, 866-872.
16. Hodgson JM, Puddey IB, Beilin LJ, Mori TA & Croft KD (1998) Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: A randomized controlled trial in humans. Journal of Nutrition 128, 728-732.
17. Howes JB, Sullivan D, Lai , Nestel P, Pomeroy P, West L, Eden JA & Howes LG (2000) The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152, 143-147.
18. Joannou GE, Kelly GE, Reeder AY, Waring M & Nelson C (1995) A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. Journal of Steroid Biochemistry and Molecular Biology 54, 167-184.
19. Kanuck MP & Ellworth JL (1995) Tyrosine kinase inhibitors potentiate the induction of low-density lipoprotein receptor gene expression by hepatocyte growth factor. Life Sciences 57, 1981-1991.
20. Kelly GE, Joannou GE, Reeder AY, Nelson C & Waring M (1995) The variable metabolic response to dietary isoflavones in humans. Proceedings of the Society for Experimental Biology and Medicine 208, 40-43.
21. Khosla P, Samman S & Carroll KK (1991) Decreased receptor-mediated LDL catabolism in casein-fed rabbits preceded the increase in plasma cholesterol levels. Journal of Nutritional Biochemistry 2, 203-209.
22. Kirk EA, Sutherland P, Wang SA, Chait A & LeBoeuf RC (1998) Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. Journal of Nutrition 128, 954-959.
23. Lamon-Fava S (2000) Genistein activates apolipoprotein A-I gene expression in the human hepatoma cell line Hep G2. Journal of Nutrition 130, 2489-2492.
24. Lamon-Fava S, Ordova JM & Schaefer EJ (1999) Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter. Arteriosclerosis, Thrombosis and Vascular Biology 19, 2960-2965.
25. Lovati MR, Manzoni C, Gianazza E, Arnoldi A, Kurowska E, Carroll KK & Sirtori CR (2000) Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. Journal of Nutrition 130, 2543-2549.
26. Lyons Wall PM, Choudury N, Gerbrandy EA amp; Truswell A (1994) Increase of high-density lipoprotein cholesterol at ovulation in healthy women. Atherosclerosis 105, 171-178.
27. Markiewicz L, Garey J, Adlercreutz H & Gurpide E (1993) In vitro bioassay of non-steroidal phytoestrogens. Journal of Steroid Biochemistry 45, 399-405.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985) Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
29. Merz-Demlow BE, Duncan AM, Wangen KE, Xu X, Carr TP, Phipps WR & Kurzer MS (2000) Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. American Journal of Clinical Nutrition 71, 1462-1469.
30. Milligan SR, Balasubramanian AV & Kalita JC (1998) Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. Environmental Health Perspectives 106, 23-26.
31. Muesing RA, Miller VT, LaRosa JC, Stoy DB & Phillips EA (1992) Effects of unopposed conjugated equine estrogen on lipoprotein composition and apolipoprotein-E distribution. Journal of Clinical Endocrinology and Metabolism 75, 1250-1254.
32. Nagata C, Kabuto M, Kurisu Y & Shimizu H (1997) Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutrition and Cancer 29, 228-233.
33. Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD & West L (1999) Isoflavones from red clover improve systemic arteial compliance but not plasma lipids in menopausal women. Journal of Clinical Endocrinology and Metabolism 84, 895-898.
34. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A & Abbey M (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arteriosclerosis, Thrombosis and Vascular Biology 17, 3392-3398.
35. Nilausen K & Meinertz H (1999) Lipoprotein(a) and dietary proteins: Casein lowers lipoprotein(a) concentrations as compared with soy protein. American Journal of Clinical Nutrition 69, 419-425.
36. Potter SM (1998) Soy protein and cardiovascular disease: The impact of bioactive components in soy. Nutrition Reviews 56, 231-235.
37. Samman S, Lyons Wall PM, Chan GS, Smith SJ & Petocz P (1999) The effect of supplementtion with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Artherosclerosis 147, 277-283.
38. Samman S & Truswell A (1993) The Friedewald equation for the determination of low density lipoprotein cholesterol: A special case. American Journal of Clinical Nutrition 58, 928-929.
39. Simons LA, Von Konigsmark M, Simons J & Celermajer DS (2000) Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy postmenopausal women. American Journal of Cardiology 85, 1297-1301.
40. Sirtori CR, Gianazza E, Manzoni C, Lovati MR, Murphy PA (1997) Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. American Journal of Clinical Nutrition 65, 166-167.
41. Tikkanen MJ (1996) Estrogens, progestins and lipid metabolism. Maturitas 23S, 51-55.
42. 2+ precipitation procedure for quantification of high-density lipoprotein cholesterol. Clinical Chemistry 28, 1379-1388.